With current economic pressures and tightening market conditions for pharmaceutical companies, it is more important than ever to arm sales and marketing teams with Next Best Action (NBA) solutions to streamline their engagement with healthcare professionals (HCPs). But what does “best” really mean? Today’s Trends: Data Evolution and the Demand for Personalized Engagement We are […]
Only 52% of surveyed pharma executives say they are successfully optimizing engagement across HCP touchpoints, yet 98% say that it’s important to create and implement an omnichannel strategy. What can we learn from the 52% about how to successfully integrate Next Best Action (NBA) programs in omnichannel strategies? Alan Kalton, Senior Vice President, Global Sales […]
3-part Podcast Series Presented by Eularis with Industry Experts Artificial Intelligence is evolving from being an important strategic investment to a must-have at scale today for pharmaceutical companies. More specifically, much of the pharmaceutical industry is introducing artificial intelligence powered next best action (NBA) to drive proactive business intelligence into commercial execution. NBA, also known […]
After navigating unprecedented disruption and adapting go-to-market actions, expectations for customer interactions have fundamentally changed. Companies must be more intelligent and strategic than ever in customer engagement. How are leaders gaining an edge? Machine learning and artificial intelligence are becoming linchpin programs in commercial operations. As AI continues to mature, the utilization of machine learning […]
Aktana achieved recognition with its second consecutive inclusion as a vendor in the category of Life Science Personalization Engine in the 2022 Gartner® Hype Cycle™ for Life Science Commercial Operations. Introduced in the 2021 report, the Life Science Personalization Engine category reflects the industry’s digital acceleration and shift toward more customer-centric engagement strategies as a […]
Almirall LLC, a global biopharmaceutical company focused on skin health, was founded in Barcelona, Spain, in 1943 and today has offices in 21 countries including the U.S. Its innovative medicines are prescribed for a range of dermatology therapeutic areas, including actinic keratosis, acne, psoriasis, and atopic dermatitis. While an innovator in medicines for the skin, […]
What happens when you finally close the marketing loop, and how do you get there? by Toni Cejas The marketing strategies that life sciences organizations employ progress and mature over time based on the way they understand their customers’ needs. What often starts as best-guess tactics becomes more finely tuned as client insights and data […]
Many life sciences organizations assume their data needs to be perfect to create impactful business opportunities from AI. “This is just not correct. The data is not, and will not ever be, perfect—especially at scale,” says Youssef Idelcaid, Senior Director of Data Science at Genentech. “AI data should be clean enough and good enough to […]
Shaping Your Data Science Strategy with Youssef Idelcaid In Episode 15 of Contextual Intelligence, we interview Youssef Idelcaid, the senior director of data science for Commercial, Medical and Government Affairs at Genentech. Before Genentech, Youssef spent the last decade driving AI and digital projects at L’Oreal and Levi Strauss. Now, he’s leveraging his experience from […]
by Aisha Fiagan and Paolo Mensitieri With all of the noise in pharma sales and marketing channels today, life sciences organizations experience major challenges reaching and engaging with their intended customers. The traditional pharma commercial model is falling flat. In order to overcome these hurdles, life sciences organizations need to turn to innovative technology to […]